Compare RDCM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDCM | TKNO |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.2M | 236.6M |
| IPO Year | 1997 | 2021 |
| Metric | RDCM | TKNO |
|---|---|---|
| Price | $13.70 | $4.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 88.7K | ★ 150.1K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.57 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $68,901,000.00 | $39,801,000.00 |
| Revenue This Year | $18.86 | $8.79 |
| Revenue Next Year | $11.39 | $10.52 |
| P/E Ratio | $21.86 | ★ N/A |
| Revenue Growth | ★ 17.27 | 9.50 |
| 52 Week Low | $9.88 | $3.94 |
| 52 Week High | $15.98 | $10.37 |
| Indicator | RDCM | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 46.96 |
| Support Level | $12.69 | $4.53 |
| Resistance Level | $13.14 | $4.87 |
| Average True Range (ATR) | 0.43 | 0.28 |
| MACD | 0.15 | 0.04 |
| Stochastic Oscillator | 79.80 | 64.79 |
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.